Karin Förster - Concepedia

Author

Karin Förster

Also Known As

K Förster, K K Förster, K. Förster, Karin Förster

Publications

644

Citations

H-Index

Concepts

All Affiliations

Karin Förster is an author at AstraZeneca (Sweden) specializing in medicine, pharmacotherapy, and rheumatology.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	639
2	Allergy	2	2	425
3	Health Sciences	1	1	37
4	Allergy Medicine	1	1	298
5	Exercise Physiology	1	1	37

Karin Förster

Publications

639

Citations

H-Index

Page 1

	Year	Citations
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial William W. Busse, Eugene R. Bleecker, J Mark FitzGerald, The Lancet Respiratory Medicine AsthmaRheumatologyExtension TrialAllergyAllergy Medicine	2018	298
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling, The Lancet Respiratory Medicine AsthmaRheumatologyAllergyClinical TrialsUncontrolled Asthma	2023	127
Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study. A. Reichelt, Karin Förster, Michael J. M. Fischer, PubMed Rheumatoid DisorderPharmacologyDouble-blind StudyOsteoarthritisKnee Injuries	1994	91
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD A. Kirsten, Karin Förster, E. Radeczky, Pulmonary Pharmacology & Therapeutics Advanced Lung DiseasePulmonary PharmacologyPulmonary MedicinePharmacotherapySelective Cxcr2 Antagonist	2015	86
Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD H. Worth, Karin Förster, Göran Eriksson, Respiratory Medicine Exercise ToleranceExercisePhysiologyExercise PhysiologyPulmonary Physiology	2010	37

Page 1